What’s New at APIC

Certification: The Defining Difference

APIC has launched its Certification: The Defining Difference campaign. This state-based legislative effort encourages new infection preventionists (IPs) to become certified in infection control. APIC showed a new video at #APIC2019 explaining the importance behind certification. Learn more

Read More

Highlights from #APIC2019

Relive the excitement from APIC’s 46th Annual Conference—or see what you missed (and plan to join us next year)! We’ve put together a highlight video that captures some of the great moments from Philadelphia. Watch it now and then pre-register for APIC 2020. For those who didn’t attend, conference proceedings can be purchased here!

Read More

AN IP’s Guide to Twitter

Want to brush up on your social media skills? Well now’s your chance! APIC’s Communications Committee Chair, Angela Vassallo provides a Twitter 101 and outlines the top ways social media can benefit IPs in this 2015 Prevention Strategist article.

Read More
More Recent Announcements

Spotlight

Publications

Prevention Strategist—Summer 2019

06/20/2019

Highlights:

  • Capitol Comments: APIC engages in pro-vaccine advocacy while vaccine misinformation is on the rise
  • The making of a model: APIC updates its Competency Model for the IP
  • Curiosity and compassion: A conversation with Elaine Larson
  • Accreditation Focus Series: The sterilization-focused system tracer and how to prepare for it
  • Quality improvements in endoscope reprocessing—Creating an electronic tool to measure risk

American Journal of Infection Control—September 2019

08/30/2019

Highlights:

  • Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms
  • Preliminary analysis of the antimicrobial activity of a postoperative wound dressing containing chlorhexidine gluconate against methicillin-resistant Staphylococcus aureus in an in vivo porcine incisional wound model
  • Antipseudomonal monotherapy or combination therapy for older adults with community-onset pneumonia and multidrug-resistant risk factors: a retrospective cohort study
  • Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients
  • Implementation of strategies to liberate patients from mechanical ventilation in a tertiary-level medical center

Public Policy Updates

08/20/2019

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

Read More

08/19/2019

Antibiotic Use in the United States: Progress and Opportunities, 2018 Update

Read More

06/25/2019

Important Updates in June NHSN eNewsletter

Read More
More Updates